Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
1999-4-29
pubmed:abstractText
Endoscopic ultrasound (EUS) provides important information in the initial staging of patients with esophageal cancer. With recent modifications in chemoradiotherapy protocols, a significant number of patients have no residual tumor at esophagectomy. The high surgical morbidity and mortality might be avoided if complete response to chemoradiotherapy could be predicted. Previously published clinical trials, with relatively small patient numbers, have suggested that EUS may accurately stage esophageal cancer after chemoradiotherapy. The aim of this study was to verify the accuracy of EUS in staging esophageal cancer after effective chemoradiotherapy.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0002-9270
pubmed:author
pubmed:issnType
Print
pubmed:volume
94
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
906-12
pubmed:dateRevised
2006-4-24
pubmed:meshHeading
pubmed-meshheading:10201455-Adenocarcinoma, pubmed-meshheading:10201455-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:10201455-Carcinoma, Squamous Cell, pubmed-meshheading:10201455-Cisplatin, pubmed-meshheading:10201455-Combined Modality Therapy, pubmed-meshheading:10201455-Dose Fractionation, pubmed-meshheading:10201455-Endosonography, pubmed-meshheading:10201455-Esophageal Neoplasms, pubmed-meshheading:10201455-Esophagectomy, pubmed-meshheading:10201455-Esophagoscopy, pubmed-meshheading:10201455-Fluorouracil, pubmed-meshheading:10201455-Humans, pubmed-meshheading:10201455-Middle Aged, pubmed-meshheading:10201455-Neoplasm, Residual, pubmed-meshheading:10201455-Neoplasm Staging, pubmed-meshheading:10201455-Predictive Value of Tests, pubmed-meshheading:10201455-Sensitivity and Specificity
pubmed:year
1999
pubmed:articleTitle
Endoscopic ultrasound cannot determine suitability for esophagectomy after aggressive chemoradiotherapy for esophageal cancer.
pubmed:affiliation
Department of Gastroenterology, The Cleveland Clinic Foundation, Ohio 44195, USA.
pubmed:publicationType
Journal Article